Target intelligence / Profile preview

Nuclear factor erythroid 2-related factor 2 pathway (NRF2 pathway)

Target
NRF2 pathway
Molecular classification
Other (signaling pathway), Transcription factor (NRF2 is a transcription factor)
01

Overview

The canonical pathway mediating the effects of sulforaphane is the KEAP1-NRF2 pathway, sometimes referred to as the NRF2 pathway. This signaling cascade regulates cellular adaptation to oxidative and chemical stress, centering on the NRF2 transcription factor, which—when liberated from KEAP1-mediated degradation—translocates to the nucleus and induces the expression of a battery of antioxidant and detoxifying enzymes. Sulforaphane is the most potent natural activator of this pathway, and it exerts its cytoprotective, anti-inflammatory, and chemopreventive effects primarily through this mechanism. The pathway is critical for defense against a variety of chronic diseases, including cancer and neurodegeneration[2][4][7].

Other names
KEAP1-NRF2 pathwayNrf2 pathwayKeap1-Nrf2-ARE pathway
02

Mechanism of action

Activation of NRF2 transcription factor (often by modifying cysteines on KEAP1, releasing NRF2 to translocate to the nucleus)\nUpregulation of antioxidant and detoxification genes\nInhibition of pro-inflammatory NF-κB signaling

03

Biological functions

Antioxidant defenseRegulation of cytoprotective gene expressionCellular detoxificationInflammation suppressionCell survival and adaptation to stress
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseLiver diseasePsychiatric disorders
05

Safety considerations

Overactivation of NRF2 may contribute to tumor progression and chemoresistance in some cancersGeneral safety risks with high-dose supplementation remain under clinical investigation
06

Interacting drugs

Sulforaphane (the dietary compound/agonist itself)

3 more in the full profile.

07

Biomarkers

NQO1 (NAD(P)H quinone dehydrogenase 1) expressionHO-1 (heme oxygenase-1) expressionGCLC (glutamate-cysteine ligase catalytic subunit) expression

Beyond the preview

Go deeper on Nuclear factor erythroid 2-related factor 2 pathway (NRF2 pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear factor erythroid 2-related factor 2 pathway (NRF2 pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call